Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
NuCana
Biotech
Another of NuCana's retooled chemotherapies struggles in clinic
NuCana has seen another of its reworked chemotherapies struggle to prove itself in the clinic, halving the biotech’s stock.
James Waldron
Aug 30, 2024 7:50am
NuCana's retooled chemo drug comes up short in pancreatic cancer
Aug 21, 2019 11:02am
Cancer, gene therapy biotechs raise $303M in IPO bonanza
Sep 28, 2017 3:53am
EuroBiotech: More Articles of Note
Sep 14, 2017 8:03am
EuroBiotech Report—Cellectis, NuCana, Nightstar, Destiny and Verona
Sep 7, 2017 2:36pm
NuCana plans $115M IPO to test retooled chemotherapies
Sep 6, 2017 7:48am
